SOURCE: SensioTec, Inc

December 04, 2013 13:46 ET

Sensiotec to Demonstrate the Virtual Medical Assistant®

The World's First Non-Contact Patient Monitoring System at the 5th Annual mHealth Summit in Washington, D.C.

ATLANTA, GA and WASHINGTON, DC--(Marketwired - Dec 4, 2013) -  Sensiotec, a leading digital health application provider, is set to exhibit the Virtual Medical Assistant® (VMA) during the 5th Annual mHealth Summit in Washington, D.C., December 8-11, 2013. The VMA is the first FDA-cleared, remote, non-contact, real-time cardiorespiratory and patient motion monitor which provides scalable, high value, low cost, location-agnostic patient care. The VMA measures heart and lung function as well as body movement, streaming critical spot and trend data to a nurse's station, tablet device, or smartphone -- all without electrodes, sensors or pads ever touching the patient directly or indirectly.

The mHealth conference brings together 5,000 health and technology influencers, developers, policy makers and business leaders across the mHealth ecosystem, making it an ideal venue for Sensiotec's VMA. "The mHealth conference provides a valuable audience to showcase the VMA's capabilities as the world's first non-contact patient monitoring platform," explains Sensiotec CEO, Robert Arkin. 

The VMA helps meet critical unmet needs and enables providers to do more with less by utilizing the proven benefits of continuous cardiorespiratory and patient motion monitoring to reduce risk, improve care and increase productivity. As a decision support tool, the VMA helps identify potential healthcare crises at an early stage and reduces complications associated with certain common chronic illnesses. The VMA can help hospitals extend continuous patient monitoring to a larger patient population at a fraction of today's costs, supporting the transition in healthcare delivery from the hospital to intermediate care and the "health home."

About Sensiotec
Sensiotec, a leading digital health application provider, was formed in 2008, and headquartered in Atlanta at the Georgia Institute of Technology's Advanced Technology Development Center, named by Forbes as one of the "Top 12 Business Incubators Changing the World." Recently, Sensiotec was recruited to ATDC Select, ATDC's flagship program for high potential startups. In 2012, Sensiotec received the Healthcare Heroes Award for Innovation for development of the Virtual Medical Assistant®. For more information, visit www.sensiotec.com.

About the Virtual Medical Assistant® (VMA)
The VMA is the first FDA-cleared, remote, non-contact, real-time cardiorespiratory and patient motion monitor which provides scalable, high value, low cost, location-agnostic patient care. The VMA measures heart and lung function as well as body movement, streaming critical spot and trend data to a nurse's station, tablet device, or smartphone -- all without electrodes, sensors or pads ever touching the patient directly or indirectly.

Contact Information